Abstract
Drug-resistant biofilm infections pose a critical global health challenge, demanding innovative therapies. We developed a butterfly-shaped aggregation-induced emission luminogen (AIEgen), 4TPE-DTB, as a potent photothermal agent for biofilm eradication. Encapsulating 4TPE-DTB into pH-responsive Cu~(2+)-tannic acid nanoparticles (CTNPs) yielded a synergistic platform (DTB@CTNPs) combining mild photothermal therapy (PTT) with controlled Cu~(2+) release. DTB@CTNPs exhibited strong bacterial membrane adhesion and acid-triggered Cu~(2+) release, specifically targeting biofilm microenvironments. 4TPE-DTB enabled NIR-Ⅱ imaging-guided therapy, permitting real-time infection localization while generating localized hyperthermia under 808 nm irradiation. The photothermal effect disrupted bacterial membranes, enhancing intracellular Cu~(2+) influx and antibacterial efficacy. In vitro, DTB@ CTNPs eradicated mature biofilms at low doses. In vivo, they effectively treated methicillin-resistant Staphylococcus aureus (MRSA) abscesses and Pseudomonas aeruginosa keratitis, demonstrating superior antibiofilm performance. This work presents a multifunctional nanoplatform synergizing AIEgen-mediated mild PTT and Cu~(2+) delivery, achieving potent bactericidal activity with minimal cytotoxicity. The strategy addresses a pressing unmet need in combating drug-resistant biofilm infections.